Overall rank by patents
#49,274
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A41D (OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES).
The verdict
Omorpho holds 5 US patents across 2 technology areas, rank #49,274 of 50,000 tracked assignees.
Omorpho, Inc. has been granted 5 US utility patents between 2024 and 2025, placing Omorpho, Inc. at rank #49,274 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 4.8 claims per patent with primary concentration in A41D (OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES). As a US Corporation, Omorpho, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Omorpho sits between OMMO Technologies, Inc. (5 patents, rank #49,270) and Onset Computer Corporations (5 patents, rank #49,278) - the closest US assignees by grant volume. The composite Innovation Score of 34.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Omorpho, Inc.'s 4.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Omorpho, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OMMO Technologies, Inc.
5 patents
OMNI USA, INC.
5 patents
OMNI-ID CAYMAN LIMITED
5 patents
OMNIVISION SEMICONDUCTOR (SHANGHAI) CO., LTD.
5 patents
ONCOBETA INTERNATIONAL GMBH
5 patents
ONCOTRACKER, INC.
5 patents
ONIRIS
5 patents
ONSET COMPUTER CORPORATIONS
5 patents
OMORPHO, INC.
5 patents
What this shows Omorpho holds 5 patents at rank #49,274, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,274 in granted patent volume.
Other assignees with the most granted patents in Omorpho's primary technology class.
Omorpho's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 54% higher than 46% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 4 | 80.0% |
| 2025 | 1 | 20.0% |
Top 2 of 2 technology areas
Overall rank by patents
#49,274
Across all tracked assignees
34.1 out of 100
How to use this portfolio
Omorpho's 5 grants land it in the top 54% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.